Prof. MUDr. Sylvie Sulková, DrSc.
Prof. MUDr. Sylvie Sulková, DrSc. je autorem těchto článků v časopise Postgraduální nefrologie:
Ahmed AK, Kamath NS, El Kossi M, Al Nahas AM. The impact of stopping inhibitors of the renin‑angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant 2010;25:3977–3982.
Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Brre P, Zhang J, Scott-Douglas N. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011;364:303–312.
Brancaccio D, Cozzolinu M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects. A combined therapeutic approach. J Am Soc Nephrol 2004;15:S21-S24
Mitra S, Chamney P, Greenwood R, Farrington K. The relationship between systemic and whole body hematocrit is not konstant during ultrafiltration on hemodialysis. J Am Soc Nephrol 2004;15:463-469.
Andreucci VE, Kerr DNS, Kopple JD. Rights of chronic renal failure patients undergoing chronic dialysis therapy. Nephrol Dial Transplant 2004;19:30-38.
Griffith TF, Chua BSY, Allen AS, Klassen PS, Reddan DN, Szczech LA. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2003;42:1260-1269.
Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching endtage renal disease: Cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003;14:1012-1021.
Cheung AK, Levin NW, Greene T, et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-3263.
Vanholder R, de Smet R, Glorieux G et al: Review on uremic toxins: classification, concentration and interindividual variability. Kidney Int 2003;63:1934-1943.
Konings CJAM, Kooman JP, Schonck M, Struijk DG, Gladziva U, Hoortnje SJ, van der Wall Bake AW, van der Sande FM, Leunissen KM. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003;18:797-803.
Kramer HM, Curhan CC, Singh A: Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study. Am J Kidney Dis 2003;41:643-650.
Venderely B, Chauveau P, Barthe N, et al. Nutrition in hemodialysis patients previously on a supplemented very low protein diet. Kidney Int 2003;63:1491-1498.
Campistol JM. Uremic myopathy. Kidney Int 2002;62:1901-1913.
Traynor JP, Simpson K, Ceddes CG, Deighan ChJ, Fox J. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002;13:2125ń2132.
Tozawa M, Iseki K, Iseki Ch, Oshiro S, Higashiuesato Y, Yamazato M, Tomiyama N, Tana T, Takishita S. Analysis of drug prescription in chronic haemodialysis patients. Nephrol Dial Transplant 2002;17:1819-1824.
Chertow GM, Burke SK, Raggi P for the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.